Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.945
+0.012 (1.24%)
Nov 7, 2024, 3:23 PM EST - Market open
RVPH Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 32 | 144 | 87 | 40 | 81 | 27 | |
Market Cap Growth | -71.25% | 65.49% | 115.01% | -49.95% | 195.66% | 6.77% | |
Enterprise Value | 25 | 139 | 64 | 7 | 114 | 32 | |
Last Close Price | 0.93 | 5.15 | 4.25 | 2.89 | 8.74 | 10.46 | |
PE Ratio | - | -3.12 | -2.93 | -5.02 | -7.08 | -34.19 | |
PB Ratio | -6.32 | 25.14 | 10.35 | 1.41 | 14.77 | -4.01 | |
P/FCF Ratio | -1.08 | -5.08 | -4.58 | -3.79 | -19.85 | -125.00 | |
P/OCF Ratio | -1.08 | -5.08 | -4.58 | -3.79 | -19.85 | -125.00 | |
EV/EBITDA Ratio | - | - | - | -0.68 | -46.95 | -85.20 | |
EV/EBIT Ratio | -0.71 | -3.52 | -2.26 | -0.68 | -46.94 | -85.05 | |
EV/FCF Ratio | -0.75 | -4.91 | -3.36 | -0.65 | -28.10 | -146.73 | |
Debt / Equity Ratio | -0.03 | - | - | - | - | -0.55 | |
Debt / FCF Ratio | -0.01 | - | - | - | - | -17.24 | |
Quick Ratio | 0.44 | 1.36 | 1.86 | 12.66 | 6.57 | 0.00 | |
Current Ratio | 0.52 | 1.38 | 1.90 | 13.39 | 6.57 | 0.00 | |
Return on Equity (ROE) | - | -556.38% | -152.43% | -49.91% | - | - | |
Return on Assets (ROA) | -233.95% | -115.85% | -70.11% | -31.45% | -34.72% | -379.02% | |
Return on Capital (ROIC) | - | -349.89% | -95.16% | -36.98% | -125.79% | - | |
Earnings Yield | -115.37% | -27.31% | -32.53% | -21.09% | -4.69% | -3.10% | |
FCF Yield | -113.00% | -19.70% | -21.82% | -26.40% | -5.04% | -0.80% | |
Buyback Yield / Dilution | -30.40% | -21.94% | -31.95% | -383.10% | -10.60% | - | |
Total Shareholder Return | -30.40% | -21.94% | -31.95% | -383.10% | -10.60% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.